Quantcast
Channel: MassDevice
Browsing all 54 articles
Browse latest View live

Image may be NSFW.
Clik here to view.

Senseonics launches Eversense implantable glucose monitor

Senseonics (NYSE:SENS) said today that its Eversense continuous glucose monitoring system is available at clinics across the U.S. The Germantown, Md.-based company also touted that it won coverage for...

View Article


Image may be NSFW.
Clik here to view.

Senseonics wins coverage from Aetna for Eversense glucose monitor

Senseonics (NYSE:SENS) said this week that won coverage from health plan provider Aetna for its Eversense continuous glucose monitoring system. Aetna provides coverage for roughly 22 million people in...

View Article


Image may be NSFW.
Clik here to view.

Senseonics wins another FDA approval for its implantable CGM

Senseonics (NYSE:SENS) said this week that it won another FDA approval for its implantable continuous glucose monitoring system, giving nurse practitioners and physicians assistants the ability to...

View Article

Image may be NSFW.
Clik here to view.

Senseonics reports mixed Q3 results

Shares in Senseonics (NYSE:SENS) fell today after the medical device maker missed EPS expectations but met sales estimates on Wall Street with its third quarter financial results. The Germantown,...

View Article

Image may be NSFW.
Clik here to view.

Senseonics CFO Elsey to retire | Personnel Moves – December 4, 2018

Senseonics (NYSE:SENS) said yesterday that its CFO R. Elsey is retiring for the company, and that it has begun searching for a permanent replacement. The Germantown, Md.-based company said that Elsey...

View Article


Image may be NSFW.
Clik here to view.

Senseonics touts first U.S. trial implant of 180-day CGM

Senseonics (NYSE:SENS) said yesterday that its Eversense XL 180-day continuous glucose sensor was implanted into the first participant of a trial designed to support a pre-market application to the...

View Article

Image may be NSFW.
Clik here to view.

Insulet taps former Medtronic finance exec McMillan as CFO | Personnel Moves...

Insulet (NSDQ:PODD) said yesterday that it tapped former Medtronic minimally invasive therapies CFO and finance VP Wayde McMillan as its new chief financial officer, replacing Michael Levitz. The...

View Article

Image may be NSFW.
Clik here to view.

Senseonics wins MRI-safe FDA nod for Eversense CGM

Senseonics announced that it has received notice from the FDA that its Eversense sensor no longer has to be removed for MRI scanning. “Based on our testing, we have demonstrated hat it is safe for...

View Article


Image may be NSFW.
Clik here to view.

Senseonics extends distribution agreement with Roche Diabetes Care

Senseonics Holdings (NYSE-American: SENS) — maker of an implantable continuous glucose monitoring system for people with diabetes — has extended its distribution agreement with Roche Diabetes Care. The...

View Article


Image may be NSFW.
Clik here to view.

Senseonics partners to provide veterans with Eversense CGM

Senseonics (NYSE:SENS) this week announced that it partnered with Geo-Med to provide access to the Eversense continuous glucose monitor to more than 9 million veterans and U.S. government staff. The...

View Article

Image may be NSFW.
Clik here to view.

Senseonics inks CGM data deal with Glooko

Senseonics (NYSE:SENS) said today that data from its Eversense continuous glucose monitoring system can be integrated into Glooko‘s diabetes data management tech. Thanks to the new partnership,...

View Article

Image may be NSFW.
Clik here to view.

HydroCision names Tranchemontagne as CEO | Personnel Moves – March 12, 2019

HydroCision said early this month that it tapped former Smith & Nephew (NYSE:SNN) exec Alain Tranchemontagne as its new chief executive officer. Prior to joining Boston-based HydroCision,...

View Article

Image may be NSFW.
Clik here to view.

Senseonics shares dip on Q4 sales miss, lowered guidance

Shares in Senseonics (NYSE:SENS) fell slightly today after the diabetes-focused device maker posted fourth quarter and full year 2018 earnings that beat loss-per-share consensus but missed sales...

View Article


Image may be NSFW.
Clik here to view.

Senseonics touts patient access program for Eversense CGM

Senseonics (NYSE:SENS) said today that it launched the Eversense Bridge Program, which is designed to improve patient access to Senseonics’ Eversense continuous glucose monitoring system. The company...

View Article
Browsing all 54 articles
Browse latest View live